PBX1 and non-small cell lung carcinoma: In non-small cell lung cancer PBX1 was recently shown to inhibit tumor growth; in patients’ tissues it is indeed downregulated through binding to the ubiquitin ligase TRIM6, which drives PBX1 proteasomal degradation (Sun et al., 2023).